DICER1 Gene Pleuropulmonary blastoma Genetic Test
Cost: AED 4400.0
Symptoms, Diagnosis, and Test Details
The DICER1 gene pleuropulmonary blastoma NGS genetic test is a diagnostic test that analyzes the DNA sequence of the DICER1 gene to identify any genetic variations or mutations that may be associated with the development of pleuropulmonary blastoma (PPB). PPB is a rare type of childhood lung cancer that primarily affects infants and young children.
The DICER1 gene provides instructions for producing an enzyme called DICER1, which plays a crucial role in the regulation of gene expression. Mutations in this gene have been found to increase the risk of developing various types of tumors, including PPB.
NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid and accurate analysis of a large number of genes simultaneously. In the context of the DICER1 gene PPB NGS genetic test, NGS technology is used to sequence the entire coding region of the DICER1 gene, as well as specific regions that are known to be associated with PPB.
The results of this genetic test can help healthcare professionals in diagnosing PPB and determining the appropriate treatment and management strategies for affected individuals. Additionally, the identification of DICER1 gene mutations through this test can also have implications for genetic counseling and family planning, as these mutations may be inherited and increase the risk of PPB in future generations.
Test Components
- DICER1 Gene Pleuropulmonary blastoma Genetic Test
Price
AED 4400.0
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Cancer
Doctor
Oncologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for DICER1 Gene Pleuropulmonary blastoma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DICER1 Gene Pleuropulmonary blastoma NGS Genetic DNA Test gene DICER1.
| Test Name | DICER1 Gene Pleuropulmonary blastoma Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for DICER1 Gene Pleuropulmonary blastoma NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DICER1 Gene Pleuropulmonary blastoma NGS Genetic DNA Test gene DICER1 |
| Test Details | DICER1 gene pleuropulmonary blastoma NGS genetic test is a diagnostic test that analyzes the DNA sequence of the DICER1 gene to identify any genetic variations or mutations that may be associated with the development of pleuropulmonary blastoma (PPB). PPB is a rare type of childhood lung cancer that primarily affects infants and young children. The DICER1 gene provides instructions for producing an enzyme called DICER1, which plays a crucial role in the regulation of gene expression. Mutations in this gene have been found to increase the risk of developing various types of tumors, including PPB. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid and accurate analysis of a large number of genes simultaneously. In the context of the DICER1 gene PPB NGS genetic test, NGS technology is used to sequence the entire coding region of the DICER1 gene, as well as specific regions that are known to be associated with PPB. The results of this genetic test can help healthcare professionals in diagnosing PPB and determining the appropriate treatment and management strategies for affected individuals. Additionally, the identification of DICER1 gene mutations through this test can also have implications for genetic counseling and family planning, as these mutations may be inherited and increase the risk of PPB in future generations. |
